Article Information
PubMed
Published By
History
- Received September 5, 2020
- Accepted October 27, 2020
- Published online December 2, 2020.
Copyright & Usage
Copyright © 2020 Zhu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Blossom Damania, Editor, University of North Carolina, Chapel Hill
Author Information
- Qian-Ying Zhua,
- Xiang-Wei Konga,
- Cong Suna,
- Shang-Hang Xieb,
- Allan Hildesheimc,
- Su-Mei Caob and
- Mu-Sheng Zenga
- aState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China
- bState Key Laboratory of Oncology in South China, Department of Cancer Prevention Research, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China
- cDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
- Address correspondence to Su-Mei Cao, caosm{at}sysucc.org.cn, or Mu-Sheng Zeng, zengmsh{at}sysucc.org.cn.
Citation Zhu Q-Y, Kong X-W, Sun C, Xie S-H, Hildesheim A, Cao S-M, Zeng M-S. 2020. Association between antibody responses to Epstein-Barr virus glycoproteins, neutralization of infectivity, and the risk of nasopharyngeal carcinoma. mSphere 5:e00901-20. https://doi.org/10.1128/mSphere.00901-20.